Development of a Lipid-encapsulated TGFβRI-siRNA Drug for Liver Fibrosis Induced by Schistosoma mansoni
PLOS Neglected Tropical Diseases · 12.09.2024 · 18 (9) · e0012502
DOI: 10.1371/journal.pntd.0012502 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 12.09.2024. Verfasst von Ying-Chou Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Liver Cirrhosis, RNA, Small Interfering, Schistosoma mansoni, Schistosomiasis mansoni. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Taipei, Taiwan to Po-Ching Cheng, LEO Foundation, Intelligent Drug Delivery and Sensing Using Microcontainers and Nanomechanics.
Abstract (Originalsprache)
Schistosoma mansoni infection leads to chronic schistosomiasis and severe hepatic fibrosis. We designed a liver-targeted lipid nanoparticle (LNP) carrying siRNA against type I TGF-β receptor (TGFβRI) mRNA to treat schistosomiasis-induced liver fibrosis in BALB/c mice. Knockdown of TGFβRI by LNP-siTGFβRI reduced LX-2 cell activation in vitro and alleviated liver fibrosis in S . mansoni -infected mice. αSMA and Col1a1 fibrotic markers in the liver tissues of infected mice were significantly suppressed in the treatment groups. In the serum of the LNP-siTGFβRI-treated groups, cytokines IFNγ, IL-1α, IL-6, IL-12, RANTES (CCL5), and TNFα increased, while GM-CSF, IL-2, IL-4, IL-10, IL-13, and KC (CXCL1) decreased compared to the control. Cell proportions were significantly altered in S . mansoni -infected mice, with increased CD56d NK cells and decreased CD19 + B cells and CD4 + T cells compared to naïve mice. Following LNP-siTGFβRI treatment, CD56d NK cells were downregulated, while B and memory Th cell populations were upregulated. The density of fibrotic regions significantly decreased with LNP-siTGFβRI treatment in a dose-dependent manner, and no systemic toxicity was observed in the major organs. This targeted siRNA delivery strategy effectively reduced granulomatous lesions in schistosomiasis-induced liver fibrosis without detectable side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.
- Department of Molecular Parasitology and Tropical Diseases, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
- Drug Metabolism & Pharmacokinetics Department, Institute for Drug Evaluation Platform, Development Center for Biotechnology, Taipei, Taiwan.
- Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, Taiwan.
- The Danish National Research Foundation and Villum Foundation's Center for Intelligent Drug Delivery and Sensing Using Microcontainers and Nanomechanics, Department of Health Technology, Technical University of Denmark.
- Center for International Tropical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
ORCID-Profile: Po-Ching Cheng
Förderung
- Ministry of Science and Technology, Taipei, Taiwan to Po-Ching Cheng
- LEO Foundation
- Intelligent Drug Delivery and Sensing Using Microcontainers and Nanomechanics
- Ministry of Science and Technology, Taiwan
- LEO Fondet
Zitieren
APA
Chen, Y. C., Lee, Y. L., Lee, C. A., Lin, T. Y., Hwu, E. E., & Cheng, P. C. (2024). Development of a Lipid-encapsulated TGFβRI-siRNA Drug for Liver Fibrosis Induced by Schistosoma mansoni. PLOS Neglected Tropical Diseases, 18(9), e0012502. https://doi.org/10.1371/journal.pntd.0012502
Vancouver
Chen YC, Lee YL, Lee CA, Lin TY, Hwu EE, Cheng PC. Development of a Lipid-encapsulated TGFβRI-siRNA Drug for Liver Fibrosis Induced by Schistosoma mansoni. PLOS Neglected Tropical Diseases. 2024;18(9):e0012502. doi:10.1371/journal.pntd.0012502
BibTeX
@article{Chen2024,
author = {Chen, Ying-Chou and Lee, Yueh-Lun and Lee, Ching-An and Lin, Tzu-Yuan and Hwu, Edwin En-Te and Cheng, Po-Ching},
title = {Development of a Lipid-encapsulated TGFβRI-siRNA Drug for Liver Fibrosis Induced by Schistosoma mansoni},
journal = {PLOS Neglected Tropical Diseases},
year = {2024},
volume = {18},
number = {9},
pages = {e0012502},
doi = {10.1371/journal.pntd.0012502}
}
EUVIMED